Home > Financial Ratios > SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY
Price to Cash Earnings (PCE)

    Back to All Ratios
AD     Remove this Ad

SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023
   PCE(x) -14.55-32.04-27.62

What is the latest Price to Cash Earnings (PCE) ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?

The latest Price to Cash Earnings (PCE) ratio of SUN PHARMA ADVANCED RESEARCH COMPANY is -14.55 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar2025-14.55
Mar2024-32.04
Mar2023-27.62

How is Price to Cash Earnings (PCE) of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 -14.55
Negative
Mar2024 -32.04
Negative
Mar2023 -27.62 -

Other Financial Ratios of SUN PHARMA ADVANCED RESEARCH COMPANY


Compare Price to Cash Earnings (PCE) ratio of peers of SUN PHARMA ADVANCED RESEARCH COMPANY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY ₹4,285.0 Cr -4.3% -2.5% -15.1% Stock Analytics
SAGILITY INDIA ₹22,166.1 Cr -2.9% -7.7% -8.2% Stock Analytics
SYNGENE INTERNATIONAL ₹17,509.7 Cr -4.6% -31% -40.2% Stock Analytics
LATENT VIEW ANALYTICS ₹8,056.6 Cr -7.9% -9.5% -13% Stock Analytics
JUST DIAL ₹5,479.9 Cr -7.7% -10.5% -22.8% Stock Analytics
AWFIS SPACE SOLUTIONS ₹2,318.6 Cr -18.7% -28.3% -48.4% Stock Analytics


SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY

-4.3%

-2.5%

-15.1%

SENSEX

-1.1%

-1.2%

5.9%


You may also like the below Video Courses